NOVARTIS N - Dusseldorf Stock Exchang
NOVARTIS N - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
NOVARTIS N - Dusseldorf Stock Exchang (NOT) - Total Assets
Latest total assets as of September 2024: €103.52 Billion EUR
Based on the latest financial reports, NOVARTIS N - Dusseldorf Stock Exchang (NOT) holds total assets worth €103.52 Billion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NOVARTIS N - Dusseldorf Stock Exchang - Total Assets Trend (2016–2023)
This chart illustrates how NOVARTIS N - Dusseldorf Stock Exchang’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NOVARTIS N - Dusseldorf Stock Exchang - Asset Composition Analysis
Current Asset Composition (December 2023)
NOVARTIS N - Dusseldorf Stock Exchang's total assets of €103.52 Billion consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.4% |
| Accounts Receivable | €7.11 Billion | 7.1% |
| Inventory | €5.91 Billion | 5.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €26.88 Billion | 26.9% |
| Goodwill | €23.34 Billion | 23.4% |
Asset Composition Trend (2016–2023)
This chart illustrates how NOVARTIS N - Dusseldorf Stock Exchang's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NOVARTIS N - Dusseldorf Stock Exchang's current assets represent 30.5% of total assets in 2023, an increase from 19.2% in 2016.
- Cash Position: Cash and equivalents constituted 13.4% of total assets in 2023, up from 5.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 47.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 26.9% of total assets.
NOVARTIS N - Dusseldorf Stock Exchang Competitors by Total Assets
Key competitors of NOVARTIS N - Dusseldorf Stock Exchang based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
NOVARTIS N - Dusseldorf Stock Exchang - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - NOVARTIS N - Dusseldorf Stock Exchang generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, NOVARTIS N - Dusseldorf Stock Exchang generates $ 14.86 in net profit.
NOVARTIS N - Dusseldorf Stock Exchang - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.11 | 0.94 | 1.04 |
| Quick Ratio | 0.90 | 0.83 | 0.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €3.13 Billion | € -2.73 Billion | € 1.24 Billion |
NOVARTIS N - Dusseldorf Stock Exchang - Advanced Valuation Insights
This section examines the relationship between NOVARTIS N - Dusseldorf Stock Exchang's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -14.9% |
| Total Assets | €99.94 Billion |
| Market Capitalization | $1.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values NOVARTIS N - Dusseldorf Stock Exchang's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NOVARTIS N - Dusseldorf Stock Exchang's assets decreased by 14.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NOVARTIS N - Dusseldorf Stock Exchang (2016–2023)
The table below shows the annual total assets of NOVARTIS N - Dusseldorf Stock Exchang from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €99.94 Billion | -14.91% |
| 2022-12-31 | €117.45 Billion | -10.88% |
| 2021-12-31 | €131.79 Billion | +3.14% |
| 2020-12-31 | €127.78 Billion | +7.95% |
| 2019-12-31 | €118.37 Billion | -18.68% |
| 2018-12-31 | €145.56 Billion | +9.38% |
| 2017-12-31 | €133.08 Billion | +2.27% |
| 2016-12-31 | €130.12 Billion | -- |